Trial Profile
The effect of sacubitril/valsartan on pharmacokinetics and pharmacodynamics of furosemide.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jan 2018
Price :
$35
*
At a glance
- Drugs Sacubitril/valsartan (Primary)
- Indications Heart failure
- Focus Pharmacodynamics; Pharmacokinetics
- 16 Jan 2018 New trial record
- 09 Jan 2018 Results published in the British Journal of Clinical Pharmacology